Drug Information

Drug General Information
Drug ID
D01NAM
Former ID
DCL001108
Drug Name
ELB-139
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Discontinued in Phase 2 [547900]
Therapeutic Class
Psychiatric
Company
Elbion AG; 4AZA Bioscience
Formula
C14H16ClN3O
Canonical SMILES
C1CCN(CC1)C2C=NC(=O)N2C3=CC=C(C=C3)Cl
InChI
1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-13(10-16-14(18)19)17-8-2-1-3-9-17/h4-7,10,13H,1-3,8-9H2
InChIKey
QVAPXAJYAPCWAI-UHFFFAOYSA-N
PubChem Compound ID
56841654
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Modulator [536166]
References
Ref 547900Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020261)
Ref 536166Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.